Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M227,360Revenue $M58,831Net Margin (%)15.6Z-Score3.2
Enterprise Value $M240,585EPS $3.7Operating Margin %18.5F-Score6
P/E(ttm))25.3Cash Flow Per Share $0Pre-tax Margin (%)18.3Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %3.1Quick Ratio1.0Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %4.2Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %-1.1ROA % (ttm)7.3Higher Current Ratio y-yY
Dividend Yield %2.9Insider Buy (3m)0ROE % (ttm)12.3Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M2,447ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with NVS

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVSDodge & Cox 2014-06-30 Add0.4%$82.51 - $90.98
($87.73)
$ 93.717%Add 10.04%51,102,219
NVSLee Ainslie 2014-06-30 Sold Out -0.42%$82.51 - $90.98
($87.73)
$ 93.717%Sold Out0
NVSLee Ainslie 2014-03-31 Add0.1%$78.2 - $83.82
($81.23)
$ 93.7115%Add 31.52%351,580
NVSPRIMECAP Management 2014-03-31 Reduce-0.26%$78.2 - $83.82
($81.23)
$ 93.7115%Reduce -10.13%24,014,586
NVSLee Ainslie 2013-12-31 Reduce-0.56%$72.96 - $80.39
($77.55)
$ 93.7121%Reduce -66.76%267,321
NVSLee Ainslie 2013-06-30 Add0.2%$68.42 - $75.5
($72.61)
$ 93.7129%Add 39.5%741,689
NVSJohn Hussman 2013-06-30 Reduce-0.52%$68.42 - $75.5
($72.61)
$ 93.7129%Reduce -47.49%218,900
NVSVanguard Health Care Fund 2013-06-30 Sold Out -0.2%$68.42 - $75.5
($72.61)
$ 93.7129%Sold Out0
NVSLee Ainslie 2013-03-31 Buy 0.49%$63.3 - $71.32
($67.87)
$ 93.7138%New holding, 531689 sh.531,689
NVSVanguard Health Care Fund 2013-03-31 Reduce-0.71%$63.3 - $71.32
($67.87)
$ 93.7138%Reduce -85.39%726,200
NVSDodge & Cox 2012-12-31 Add0.11%$58.97 - $63.96
($61.79)
$ 93.7152%Add 2.65%48,438,459
NVSDodge & Cox 2012-09-30 Add0.12%$55.24 - $61.51
($58.49)
$ 93.7160%Add 3.23%47,187,759
NVSMario Gabelli 2012-03-31 Reduce$53.31 - $58.33
($52.37)
$ 93.7179%Reduce -37.42%11,740
NVSMichael Price 2012-03-31 Sold Out -1.3%$53.31 - $58.33
($52.37)
$ 93.7179%Sold Out0
NVSJohn Hussman 2012-03-31 Reduce-0.14%$53.31 - $58.33
($52.37)
$ 93.7179%Reduce -22.44%515,000
NVSMichael Price 2011-06-30 Buy 1.29%$54.23 - $64.52
($59.61)
$ 93.7157%New holding, 144969 sh.144,969
NVSVanguard Health Care Fund 2011-06-30 Add0.45%$54.23 - $64.52
($59.61)
$ 93.7157%Add 30.01%4,869,880
NVSMario Gabelli 2011-06-30 Add$54.23 - $64.52
($59.61)
$ 93.7157%Add 65.83%20,215
NVSMario Gabelli 2011-03-31 Reduce$52.75 - $59.24
($56.19)
$ 93.7167%Reduce -95.51%12,190
NVSVanguard Health Care Fund 2010-12-31 Reduce-0.42%$53.41 - $59.77
($57.3)
$ 93.7164%Reduce -21.07%4,869,880
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVS Dodge & Cox 2014-06-3051,102,2192.094.4+10.04%
NVS Jean-Marie Eveillard 2014-06-3013,06000
NVS PRIMECAP Management 2014-06-3023,846,2360.972.4-0.7%
NVS Tweedy Browne 2014-06-30288,8250.010.56-0.92%
NVS John Hussman 2014-06-30214,0000.011.5-3.25%
NVS Mario Gabelli 2014-06-3010,24000-4.66%
NVS Lee Ainslie 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


NVS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVS :

    Quarterly/Annual Reports about NVS:

      News about NVS:

      Articles On GuruFocus.com
      Sarah Ketterer’s Causeway International Value Fund Reports Top Five Aug 31 2014 
      I Am Sure This Pharma-Company Suits Your Portfolio Aug 28 2014 
      A Strong Candidate for Investor´s Portfolios Aug 12 2014 
      Novartis: Ten Years of Solid ROE Jul 31 2014 
      Tweedy Browne Global Reports Their Second Quarter Portfolio Jul 18 2014 
      Sarah Ketterer’s Causeway International Value’s Top Five Holdings Jun 05 2014 
      Top Held European Stocks Highlighted by Health Care and Oil and Gas Stocks May 29 2014 
      Can Pfizer Make Up Its Loss? May 09 2014 
      These Three Pharmaceutical Companies Shake The Market With Their Deal Apr 27 2014 
      The Tweedy Browne Global Value Fund's Top First Quarter Holdings Apr 22 2014 


      More From Other Websites
      Novartis Rises Most in Five Months on Heart-Drug Trial Sep 01 2014
      Novartis Japan admits concealing drug side effects Aug 31 2014
      Heart drug launch could be "most exciting ever", says Novartis Aug 31 2014
      Tests promise 'blockbuster' new heart failure drug Aug 31 2014
      Tests promise 'blockbuster' new heart failure drug Aug 30 2014
      Novartis' investigational heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs.... Aug 30 2014
      Study: Novel heart failure drug shows big promise Aug 30 2014
      [$$] Novartis Data Show Heart Drug Beats Rival Aug 30 2014
      Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in... Aug 30 2014
      New Novartis Drug Effective in Treating Heart Failure Aug 30 2014
      Novartis Heart Failure Drug Tops Standard in Study Aug 30 2014
      Predicting PARADIGM-HF, Or What To Expect When You're Expecting Aug 27 2014
      [video] A sensor to swallow with your medicine Aug 25 2014
      Novartis to Invest $35M in Gamida Cell for 15% Equity Aug 20 2014
      Why Novartis (NVS) Stock Is Gaining Today Aug 19 2014
      Novartis to invest in Israel's Gamida Cell, could buy out company Aug 19 2014
      [video] Eyeball injections equal eye-popping profits Aug 14 2014
      Cancer: Unpronounceable Drugs, Incomprehensible Prices Aug 13 2014
      Novartis loses new bid to dismiss U.S. lawsuit over kickbacks Aug 07 2014
      Novartis loses new bid to dismiss U.S. lawsuit over kickbacks Aug 07 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK